|
COPYRIGHT 2005 Thomson Financial Inc.
Under sweeping new ethics rules unveiled Feb. 1 by National Institutes of Health Director Elias Zerhouni, MD, all NIH employees will be barred from consulting and other forms of employment, whether paid or unpaid, with pharmaceutical, biotechnology, and medical device companies.
The flat consulting ban and other new restrictions...
Read the full article for free courtesy of your local library.
|